↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

73 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   2011-2012 seasonal flu vaccine   -   -   -   -   2件:
3,
113 
 2   4-aminopyridine   Dalfampridine   D04127   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   2件:
3,
13 
 3   4-cholesten-3-one, oxime   -   -   -   -   2件:
2,
3 
 4   4-cholesten-3-one,oxime   -   -   -   -   1件:
3 
 5   Adipose derived mesenchymal stem cell   -   -   -   -   1件:
3 
 6   Amifampridine   Amifampridine   D10228   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   3件:
3,
11,
12 
 7   Amifampridine phosphate   Amifampridine   D10228   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   3件:
3,
11,
12 
 8   Amifampridine phosphate 10 mg oral tablet   Amifampridine   D10228   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   1件:
3 
 9   Avxs-101   -   -   -   -   1件:
3 
 10   Avxs-101 (previously known as scaav9.cb.smn)   -   -   -   -   1件:
3 
 11   Biocarn   -   -   -   -   1件:
3 
 12   Branaplam   Branaplam   -   -   -   1件:
3 
 13   Celecoxib   Celecoxib   D00567   1件: PTGS2   20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   8件:
2,
3,
34,
46,
70,
89,
161,
271 
 14   Ck-2127107   Reldesemtiv   D11363   1件: TNNC2   1件: Calcium signaling pathway   2件:
2,
3 
 15   Ck-2127107 150 mg   Reldesemtiv   D11363   1件: TNNC2   1件: Calcium signaling pathway   1件:
3 
 16   Ck-2127107 450 mg   Reldesemtiv   D11363   1件: TNNC2   1件: Calcium signaling pathway   1件:
3 
 17   Human anti-promyostatin monoclonal antibody   -   -   -   -   1件:
3 
 18   Hydroxyurea   Hydroxyurea   D00341   1件: RRM2   6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   8件:
3,
13,
19,
20,
65,
85,
86,
284 
 19   Isis 396443   -   -   -   -   1件:
3 
 20   Isis 396443 (biib058)   -   -   -   -   1件:
3 
 21   Itraconazole   Itraconazole   D00350   -   -   4件:
3,
65,
227,
299 
 22   Leuprolide   Leuprolide   D00989, D08113   1件: GNRHR   2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction   5件:
1,
2,
3,
51,
76 
 23   Levocarnitine   Levocarnitine   D02030, D02176, D04713   -   -   3件:
3,
53,
97 
 24   Lmi070   -   -   -   -   1件:
3 
 25   Mestinon   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
11 
 26   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 27   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 28   Nerve growth factor   Nerve growth factor   -   -   -   2件:
3,
90 
 29   Norditropin simplexx   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   4件:
3,
78,
193,
195 
 30   Norditropin simplexx 15 mg/1.5 ml   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   1件:
3 
 31   Nusinersen   Nusinersen   D10881   1件: SMN2   1件: RNA transport   1件:
3 
 32   Olesoxime   -   -   -   -   2件:
2,
3 
 33   Onasemnogene abeparvovec   -   -   -   -   1件:
3 
 34   Onasemnogene abeparvovec-xioi   -   -   -   -   1件:
3 
 35   Orfiril saft   -   -   -   -   1件:
3 
 36   Paracetamol   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   5件:
3,
6,
13,
35,
46 
 37   Paracetamol 120mg/5ml oral suspension   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
3 
 38   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 39   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 40   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 41   Pyridostigmine   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
3,
6,
11,
256 
 42   Pyridostigmine bromide   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
256 
 43   Riluzole   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   7件:
2,
3,
5,
8,
13,
17,
206 
 44   Risdiplam   Risdiplam   D11406   1件: SMN2   1件: RNA transport   1件:
3 
 45   Ro6885247/f03   -   -   -   -   1件:
3 
 46   Ro7034067   -   -   -   -   1件:
3 
 47   Ro7034067 / f12   -   -   -   -   1件:
3 
 48   Ro7034067 / f13   -   -   -   -   1件:
3 
 49   Ro7034067/f06 with solvent (ro7034067/f08)   -   -   -   -   1件:
3 
 50   Ro7034067/f07 with solvent (ro7034067/f09)   -   -   -   -   1件:
3 
 51   Ro7034067/f12   -   -   -   -   1件:
3 
 52   Ro7034067/f13   -   -   -   -   1件:
3 
 53   Ro7090919   -   -   -   -   1件:
3 
 54   Rvg 03820   -   -   -   -   1件:
3 
 55   Salbutamol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
3,
11,
49,
85,
86,
228,
256,
299 
 56   Sesame oil   Sesame oil   D03314   -   -   1件:
3 
 57   Sesame oil, refined   Sesame oil   D03314   -   -   1件:
3 
 58   Smart   -   -   -   -   1件:
3 
 59   Sodium phenylbutyrate   Phenylbutyric acid   D05868   -   -   4件:
2,
3,
8,
251 
 60   Sodium phenylbutyrate (napb)   Phenylbutyric acid   D05868   -   -   1件:
3 
 61   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 62   Spinraza   Nusinersen   D10881   1件: SMN2   1件: RNA transport   1件:
3 
 63   Srk-015   -   -   -   -   1件:
3 
 64   Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide   -   -   -   -   1件:
3 
 65   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   7件:
1,
2,
3,
13,
78,
113,
265 
 66   Tro19622   Tro19622   -   -   -   3件:
2,
3,
13 
 67   Valproate   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   6件:
2,
3,
90,
102,
233,
256 
 68   Valproate sodium   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   1件:
3 
 69   Valproate, levocarnitine   Levocarnitine   D02030, D02176, D04713   -   -   1件:
3 
 70   Valproic acid   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   10件:
3,
5,
26,
34,
65,
89,
90,
222,
256,
331 
 71   Valproic acid (vpa)   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   1件:
3 
 72   Valproic acid and levocarnitine   Levocarnitine, Valproic acid   D00399, D02030, D02176, D04713   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   1件:
3 
 73   Volmax*30cpr 4mg r.p.   -   -   -   -   1件:
3 

先頭へ